Agfa and Mitra form joint venture
PACS developers Agfa of Mortsel, Belgium, and Mitra of Waterloo, Ontario, have formed a joint-venture company called Impax Technology to develop and sell PACS software based on Agfa’s Impax product line. The new company will be headed by Mitra chief
PACS developers Agfa of Mortsel, Belgium, and Mitra of Waterloo, Ontario, have formed a joint-venture company called Impax Technology to develop and sell PACS software based on Agfas Impax product line. The new company will be headed by Mitra chief executive Eric Peterson and will also sell Impax software to other companies.
Agfa has become the industrys leading PACS company thanks largely to the Impax software, which Mitra developed for Agfa. The companies have been in discussions for the last several months about restructuring their eight-year relationship. The joint-venture deal allows Agfa to maintain access to the Impax software while creating a new pool of potential OEM customers for Mitra. Impax Technology will be based in Waterloo.
Study Shows No Impact of Hormone Therapy on PET/CT with 18F-Piflufolastat in PCa Imaging
May 7th 2025For patients with recurrent or metastatic prostate cancer, new research findings showed no significant difference in the sensitivity of 18F-piflufolastat PET/CT between patients on concurrent hormone therapy and those without hormone therapy.
